CRBP
Corbus Pharmaceuticals Holdings, Inc.Company Information
- Company Name
- Corbus Pharmaceuticals Holdings, Inc.
- CIK
- CIK0001595097
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CRBP: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CRBP
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-11
- Last sale
- 2026-09-14
- Shares purchased (TTM)
- 11,600
- Shares sold (TTM)
- 124,497
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 13,774,689
- Shares outstanding
- 19,407,688
- Ownership
- 70.98%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 12.01%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 23 | 26 | 28 | 27 | 20 | 19 | 17 | 19 | 24 | 14 | 14 | 11 | ||||||
| Short Term Investments | 95 | 113 | 135 | 77 | 97 | 114 | 132 | 140 | 123 | 106 | 7 | 17 | ||||||
| Restricted Cash Current | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 5 | 5 | 3 | 3 | 6 | 4 | 4 | 1 | 1 | 1 | 2 | 2 | ||||||
| Assets Current | 123 | 144 | 167 | 108 | 123 | 137 | 153 | 161 | 148 | 122 | 24 | 31 | ||||||
| Restricted Cash Noncurrent | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 4 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | ||||||
| Assets | 127 | 144 | 168 | 110 | 125 | 140 | 156 | 164 | 152 | 126 | 28 | 36 | ||||||
| Other Assets Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 5 | 0 | 2 | 3 | 4 | 4 | 5 | 3 | 1 | 2 | 3 | 5 | ||||||
| Accrued Liabilities Current | 15 | 16 | 17 | 13 | 8 | 6 | 5 | 7 | 10 | 9 | 11 | 8 | ||||||
| Notes Payable Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Other Long Term Debt Current | - | - | - | - | - | - | - | - | - | 13 | 16 | 18 | ||||||
| Liabilities Current | 21 | 18 | 21 | 17 | 13 | 12 | 12 | 12 | 24 | 26 | 32 | 32 | ||||||
| Long Term Debt Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Entertainment License Agreement For Program Material Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Derivative Liabilities Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 3 | - | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 4 | ||||||
| Liabilities | 25 | 18 | 21 | 17 | 14 | 13 | 13 | 14 | 26 | 29 | 35 | 36 | ||||||
Stockholders Equity | ||||||||||||||||||
| Loans Payable | - | - | - | - | - | - | 0 | 0 | 11 | - | 16 | - | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 716 | 705 | 703 | 627 | 623 | 621 | 619 | 618 | 580 | 541 | 430 | 429 | ||||||
| Retained Earnings Accumulated Deficit | -613 | -578 | -555 | -535 | -512 | -494 | -477 | -467 | -454 | -444 | -437 | -429 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 | -0 | -0 | -0 | ||||||
| Stockholders Equity | 102 | 126 | 148 | 92 | 111 | 127 | 142 | 150 | 126 | 97 | -7 | 0 | ||||||
| Liabilities And Stockholders Equity | 127 | 144 | 168 | 110 | 125 | 140 | 156 | 164 | 152 | 126 | 28 | 36 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 19 | 18 | 18 | 13 | 12 | 12 | 12 | 12 | 11 | 11 | 4 | 4 | ||||||
| Shares Outstanding | 19 | 18 | 18 | 13 | 12 | 12 | 12 | 12 | 11 | 11 | 4 | 4 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCorbus Pharmaceuticals Holdings, Inc. (CRBP) — SEC Financial Statements & Analysis
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is a pharmaceutical preparations company, incorporated in DE. Corbus Pharmaceuticals Holdings, Inc. trades on Nasdaq as: CRBP. Corbus Pharmaceuticals Holdings, Inc. (CRBP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Corbus Pharmaceuticals Holdings, Inc. carries a market cap of $182.04M, a P/E ratio of -1.79x, a P/B ratio of 1.78x, an enterprise value of $158.67M, and an EV/EBITDA multiple of -1.49x. On profitability, it posts a Return on Equity (ROE) of -95.58%, a Return on Assets (ROA) of -80.85%, and a Return on Invested Capital (ROIC) of -125.87%. Per share, it reports EPS of $-5.25, diluted EPS of $-5.25, free cash flow per share of $-4.47, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 75.84% year-over-year and EPS growth of 10.90% year-over-year. On the balance sheet, it maintains a current ratio of 5.71x, a quick ratio of 5.49x, working capital of $101.27M, a debt-to-equity ratio of 0.24x, a debt ratio of 0.19, an interest coverage ratio of -175.95x, free cash flow of $-86.68M (TTM), and net debt of $-23.37M. Figures sourced from SEC EDGAR.
- Market Cap
- $182.04M
- P/E TTM
- -1.79x
- EPS TTM
- $-5.25
- P/B TTM
- 1.78x
- ROE TTM
- -95.58%
- ROA TTM
- -80.85%
- Debt To Equity
- 0.24x
- Free Cash Flow TTM
- $-86.68M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Corbus Pharmaceuticals Holdings, Inc. in?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) operates in the Pharmaceutical Preparations industry.
What exchange does CRBP trade on?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) trades on the Nasdaq.
Where is Corbus Pharmaceuticals Holdings, Inc. incorporated?
Corbus Pharmaceuticals Holdings, Inc. is incorporated in DE.
When was Corbus Pharmaceuticals Holdings, Inc. (CRBP)'s most recent SEC filing?
Corbus Pharmaceuticals Holdings, Inc. (CRBP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is CRBP's market cap?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a market capitalization of $182.04M as of 2026-06-30.
What is CRBP's EPS (earnings per share)?
Corbus Pharmaceuticals Holdings, Inc. (CRBP)'s trailing twelve month EPS is $-5.25 as of 2026-06-30.
What is CRBP's ROE (return on equity)?
Corbus Pharmaceuticals Holdings, Inc. (CRBP)'s trailing twelve month Return on Equity (ROE) is -95.58% as of 2026-06-30.
What is CRBP's ROA (return on assets)?
Corbus Pharmaceuticals Holdings, Inc. (CRBP)'s trailing twelve month Return on Assets (ROA) is -80.85% as of 2026-06-30.
What is CRBP's ROIC (return on invested capital)?
Corbus Pharmaceuticals Holdings, Inc. (CRBP)'s trailing twelve month Return on Invested Capital (ROIC) is -125.87% as of 2026-06-30.
What is CRBP's EV/EBITDA?
Corbus Pharmaceuticals Holdings, Inc. (CRBP)'s trailing twelve month EV/EBITDA is -1.49x as of 2026-06-30.